Scarica l'app Stockscreener
15.22
3.82%
0.56
Pre-mercato:
14.85
-0.37
-2.43%
Theravance Biopharma Inc Azioni (TBPH) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
17.95%
15.39
|
18.75 | 16.87 | 14.26 | 14.50 |
Operating Expenses
|
6.68%
29.82
|
27.95 | 27.70 | 29.96 | 25.71 |
| Benefits Costs and Expenses |
29.53
|
- | - | - | - |
| Costs And Expenses |
5.62%
29.53
|
27.95 | 27.70 | 29.96 | 25.71 |
| Operating Income/Loss |
56.89%
-14.43
|
-9.20 | -10.84 | -15.71 | -11.21 |
| Income/Loss From Continuing Operations Before Tax |
175.39%
-14.14
|
18.75 | -10.05 | -15.22 | -10.40 |
| Income Tax Expense/Benefit, Deferred |
71.89%
-1.852
|
-6.589 | 0.09 | -0.561 | -0.513 |
| Income Tax Expense/Benefit |
108.49%
-0.559
|
6.588 | 2.646 | 1.308 | 1.262 |
| Income/Loss From Continuing Operations After Tax |
12.55%
-13.58
|
-15.53 | -12.70 | -16.53 | -11.66 |
|
Net Income/Loss
|
12.55%
-13.58
|
-15.53 | -12.70 | -16.53 | -11.66 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
31,560%
49.71
|
0.157 | 49.04 | 48.75 | 48.28 |
| Diluted Average Shares |
31,560%
49.71
|
0.157 | 49.04 | 48.75 | 48.28 |
| Basic Earnings Per Share |
12.90%
-0.27
|
-0.31 | -0.26 | -0.34 | -0.24 |
| Diluted Earnings Per Share |
12.90%
-0.27
|
-0.31 | -0.26 | -0.34 | -0.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):